19 results
DEF 14A
TSBX
Turnstone Biologics Corp.
22 Apr 24
Definitive proxy
4:28pm
by which risk assessment and management is undertaken. The audit committee also monitors compliance with legal and regulatory requirements. Audit committee … of Directors, the operating requirements of the Company and the long-term interests of stockholders. In conducting this assessment, the Nominating
10-K
2023 FY
TSBX
Turnstone Biologics Corp.
21 Mar 24
Annual report
8:51pm
of functional and phenotypic assays deployed for potency assessment.
TIDAL-01 is currently deployed at two primary manufacturers for the isolation … in comparison to frequencies present in bulk TIL.
Across all the samples where we conducted this assessment, in comparison to frequencies present
10-Q
nhcrq1
1 Sep 23
Quarterly report
4:39pm
424B4
0yh3v3hsz9o5krkh
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
dpsj4t9
23 Jun 23
IPO registration (amended)
9:49pm
CORRESP
x12kh ez54fcsim0
21 Jun 23
Correspondence with SEC
12:00am
S-1
p6dvoerzrlsin3s
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
7zjubrjl edennit
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.9
z9wgym9qw656orgvy 79
12 Jun 23
IPO registration
4:28pm
CORRESP
5lhoki
12 Jun 23
Correspondence with SEC
12:00am
DRS
urfv9jat 11
15 May 23
Draft registration statement
12:00am
DRS
EX-10.9
b08dci rrc8
15 May 23
Draft registration statement
12:00am
DRS
EX-2.1
jm9s8
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next